This inventor holds 1 USPTO granted patent. Top assignee: Hangzhou Tianlong Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Limin Liang - Innovator in Nucleic Acid Technology
Introduction
Limin Liang is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of nucleic acid technology, particularly in enhancing the stability and efficiency of mRNA.
Latest Patents
Limin Liang holds 1 patent for his invention titled "C6'-substituted locked nucleic acid-modified cap analog and use thereof." This innovative cap analog improves the stability of mRNA and enhances its translation efficiency, which is crucial for various applications in biotechnology and medicine.
Career Highlights
Limin Liang is currently associated with Hangzhou Tianlong Pharmaceutical Co., Ltd. His work at this company focuses on advancing pharmaceutical technologies and developing novel solutions in the field of nucleic acids.
Collaborations
Limin Liang collaborates with talented professionals in his field, including Jinyu Zhang and Yuqing Li. Their combined expertise contributes to the innovative projects at Hangzhou Tianlong Pharmaceutical Co., Ltd.
Conclusion
Limin Liang's contributions to nucleic acid technology exemplify the importance of innovation in the pharmaceutical industry. His work continues to pave the way for advancements in mRNA applications and biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile